ADMA Biologics is trading 4.7% up at $10.00, most likely reflecting broader risk-on sentiment after no new company-specific announcement was identified for August 25, 2026.
- Latest company-related items are securities-law and shareholder-investigation notices, none explicitly tied to the pre-market move.
- Nasdaq futures are up 0.80%, with major indexes higher.
- Official releases last showed second-quarter results on August 5.